A combinative effect of low-molecular-weight heparin and intermittent pneumatic compression device for thrombosis prevention during laparoscopic fundoplication;Mažos molekulinės masės heparinų ir kintančios pneumokompresijos kojinių hipokoaguliacinis efektas laparoskopinių fundoplikacijų metu

Medicina

Volumn 46, Issue 1, 2010, Pages 18-22

  Kiudelis, Mindaugas ^a   Gerbutavičius, Rolandas ^a   Gerbutavičiene, Rima ^a   Griniute, Rasa ^a   Mickevičius, Antanas ^a   Endzinas, Žilvinas ^a   Pundzius, Juozas ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Laparoscopic fundoplication; Tissue factor pathway inhibitor

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; COAGULATING AGENT; ENOXAPARIN; FIBRINOLYTIC AGENT; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFORMED CONSENT; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LAPAROSCOPY; MALE; NONPARAMETRIC TEST; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH FUNDOPLICATION; VEIN THROMBOSIS;

ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; COAGULANTS; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; FUNDOPLICATION; HUMANS; INFORMED CONSENT; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; INTRAOPERATIVE CARE; LAPAROSCOPY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THROMBOPLASTIN; VENOUS THROMBOSIS;

EID: 77953089215     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina46010003     Document Type: Article

References (15)

1. Kiudelis M, Endzinas Z, Mickevicius A, Pundzius J. Venous tasis and deep vein thrombosis prophylaxis during laparoscopic fundoplication. Zentrallbl Chir 2002;(127):944-9.
2. Risberg B. Pathophysiological mechanisms of thromboembolism. Acta Chir Scand Suppl 1988;(550):104-14.
3. Vecchio R, Cacciola E, Martino M, Cacciola RR, MacFadyen BV. Modifications of coagulation and fibrinolytic parameters in laparoscopic cholecystectomy. Surg Endosc 2003;17(3): 428-33.
4. Lindberg F, Rasmussen I, Siegbahn A, Bergqvist D. Coagulation activation after laparoscopic cholecystectomy in spite of thromboembolism prophylaxis. Surg Endosc 2000; 14(9):858-61.
5. Di Vita G, Frazzetta M, Sciume C, Lauria Lauria G, Patti R, Leo P. Changes in the hemostatic system after laparoscopic cholecystectomy. G Chir 2000;21(5):213-8.
6. Dexter SP, Griffith JP, Grant PJ, McMahon MJ. Activation of coagulation and fibrinolysis in open and laparoscopic cholecystectomy. Surg Endosc 1996;10(11):1069-74.
7. Caprini JA, Arcelus JI, Laubach M, Size G, Hoffman KN, Coats RW, et al. Postoperative hypercoagulability and deepvein thrombosis after laparoscopic cholecystectomy. Surg Endosc 1995;9(3):304-9.
8. Okuda Y, Kitajima T, Egawa H, Hamaguchi S, Yamaguchi S, Yamazaki H, et al. A combination of heparin and an intermittent pneumatic compression device may be more effective to prevent deep-vein thrombosis in the lower extremities after laparoscopic cholecystectomy. Surg Endosc 2002;16:781-4.
9. Broze GJJ. Tissue factor pathway inhibitor. Thromb Haemost 1995;95:90-3.
10. Killewich LA, Cahan MA, Hanna DJ, Murakami M, Uchia T, Wiley LA, et al. The effect of external pneumatic compression on regional fibrinolysis in a prospective randomized trial. J Vasc Surg 2002;36(5):953-8.
11. Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA. External pneumatic compression and fibrinolysis in abdominal surgery. J Vasc Surg 2000;32(3):537-43.
12. Jacobs DG, Piotrowski JJ, Hoppensteadt DA, Salvator AE, Fareed J. Hemodinamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results. J Trauma 1996;40:710-7.
13. Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R, et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997;226:306-13.
14. Giddings JC, Morris RJ, Ralis HM, Jennings GM, Davies DA, Woodcock JP. Systemic haemostasis after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis. Clin Lab Haematol 2004;26(4):269-73.
15. Chouhan VD, Comerota AJ, Sun L, Harada R, Gaughan JP, Rao AK. Inhibition of tissue factor pathway during intermittent pneumatic compression: a possible mechanism for antithrombotic effect. Arterioscler Thromb Vasc Biol 1999; 19(11):2812-7.